26.50DKK+0.38%Mkt Cap: 1.64B $P/E: 19.921d ago
Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neu…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap1.64B $
Enterprise Value1.72B $
Revenue (TTM)139.58M $
Gross Profit84.27M $
Net Income (TTM)12.14M $
Revenue/Share0.3286 USD
Last Price26.50 DKK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees4.5K
CountryDK
SectorHealthcare
IndustryMedical Devices
ISINIS0000000040
Valuation
P/E (Trailing)19.92
P/E (Forward)15.43
PEG—
EV/EBITDA78.43
EV/Revenue12.30
P/S11.77
P/B1.92
EPS (TTM)1.33
EPS (Forward)1.72
52W Range
25.0012% of range37.90
52W High37.90 DKK
52W Low25.00 DKK
Profitability
Gross Margin62.30%
Oper. Margin9.74%
EBITDA Margin15.68%
Profit Margin8.97%
ROE9.36%
ROA4.82%
Growth
Revenue Growth14.60%
Earnings Growth21.40%
Cash Flow & Leverage
Operating CF19.32M $
CapEx (TTM)4.71M $
FCF Margin7.69%
FCF Yield0.65%
Net Debt66.90M $
Net Debt/EBITDA3.06
Balance Sheet
Debt/Equity0.61
Current Ratio1.21
Quick Ratio0.63
Book Value/Sh13.78 DKK
Cash/Share0.2190 DKK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 DKK
Div. Yield—
5Y Avg Yield0.39%
Payout Ratio0.00%
Ex-Div DateMar 13, 2020
Pay Date—
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)32.90 DKK
Upside (mean)+24.2%
Target Range29.00 DKK – 40.00 DKK
DKK29.00+24.2% to meanDKK40.00
# Analysts5
Ownership
Shares Out.425.80M
Float157.31M
Insiders12.41%
Institutions79.40%
Technical
SMA 5026.69 (-0.7%)
SMA 20030.10 (-11.9%)
Beta0.45
S&P 52W Chg20.25%
Avg Vol (30d)58.28K
Avg Vol (10d)191.23K
Technical Indicators
RSI (14)47.3
MACD-0.0863
MACD Signal-0.0780
MACD Hist.-0.0083
BB Upper27.18 DKK
BB Middle26.53 DKK
BB Lower25.87 DKK
BB Width4.92%
ATR (14)0.5376 DKK
Vol Ratio (20d)1.19x